Lars Jørgensen

Title: Lars Jørgensen: Innovator in Therapeutic Compounds

Introduction

Lars Jørgensen is a notable inventor based in Ballerup, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of small molecule modulators of IL-17. His work has implications for treating various dermal diseases, showcasing his commitment to advancing medical science.

Latest Patents

Lars Jørgensen holds a patent for a compound described as small molecule modulators of IL-17. This invention relates to a compound according to formula I and pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention further encompasses the use of these compounds in therapy, pharmaceutical compositions containing them, and methods for treating diseases, particularly dermal diseases, with these compounds. The patent highlights his innovative approach to developing new therapeutic options.

Career Highlights

Throughout his career, Lars has worked with prominent companies in the pharmaceutical industry, including Leo Pharma A/S and Leo Laboratories Limited. His experience in these organizations has allowed him to contribute to significant advancements in drug development and therapeutic solutions.

Collaborations

Lars has collaborated with esteemed colleagues in his field, including Kevin Neil Dack and Xifu Liang. These partnerships have likely enriched his research and contributed to the success of his inventions.

Conclusion

Lars Jørgensen's work in developing small molecule modulators of IL-17 represents a significant advancement in therapeutic options for dermal diseases. His contributions to the pharmaceutical industry reflect his dedication to innovation and improving patient outcomes.